In addition, the findings from Clinical Proteomic Tumor Analysis Consortium (CPTAC) illustrated that the levels of CKS1B protein expression were elevated in pancreatic cancer contrast with normal samples (Figure 1C), revealing that the mRNA and protein expressions of CKS1B were comparable across multiple databases. This evidence concerns the gene CKS1B and familial pancreatic carcinoma.